Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1959 7
1960 19
1961 18
1962 25
1963 46
1964 51
1965 53
1966 42
1967 44
1968 49
1969 57
1970 56
1971 63
1972 87
1973 81
1974 66
1975 66
1976 98
1977 95
1978 82
1979 103
1980 95
1981 108
1982 98
1983 110
1984 118
1985 110
1986 104
1987 82
1988 87
1989 97
1990 83
1991 81
1992 69
1993 61
1994 60
1995 82
1996 66
1997 76
1998 95
1999 78
2000 85
2001 77
2002 91
2003 130
2004 188
2005 285
2006 370
2007 308
2008 332
2009 317
2010 266
2011 284
2012 260
2013 261
2014 249
2015 234
2016 216
2017 226
2018 244
2019 254
2020 279
2021 283
2022 289
2023 263
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

8,177 results

Results by year

Filters applied: . Clear all
Page 1
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
Fung S, Syed YY. Fung S, et al. Drugs. 2022 Sep;82(13):1403-1410. doi: 10.1007/s40265-022-01763-7. Epub 2022 Aug 26. Drugs. 2022. PMID: 36018461 Free PMC article. Review.
Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere(); SCS triamcinolone acetonide) is a corticosteroid approved in the USA for the treatment of macular edema associated with uveitis. ...Recently, a triamcinolone acet
Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere(); SCS triamcinolone acetonide) is
A Comparison of Characteristic Properties and Qualitative Difference between Three Kinds of Triamcinolone Acetonide.
Shimamura S, Kawai K, Odontuya D, Ichihashi T. Shimamura S, et al. Tokai J Exp Clin Med. 2017 Jul 20;42(2):67-70. Tokai J Exp Clin Med. 2017. PMID: 28681365 Free article.
METHODS: Kenacort-A, the newer form of MaQaid, and the older form of MaQaid were used. ...It had a small mean particle dia (almost the same size as the newer form of MaQaid and Kenacort-A). Kenacort-A was dispersed while the older form of …
METHODS: Kenacort-A, the newer form of MaQaid, and the older form of MaQaid were used. ...It had a small mean particle dia (al …
Intravitreal triamcinolone.
Tao Y, Jonas JB. Tao Y, et al. Ophthalmologica. 2011;225(1):1-20. doi: 10.1159/000317909. Epub 2010 Aug 7. Ophthalmologica. 2011. PMID: 20693817 Free article. Review.
BACKGROUND: to provide an update on the intravitreal use of triamcinolone acetonide. METHODS: Review of literature regarding triamcinolone-related research. RESULTS: after the introduction of bevacizumab and ranibizumab into clinical practice, intravitreal …
BACKGROUND: to provide an update on the intravitreal use of triamcinolone acetonide. METHODS: Review of literature regarding …
Intravitreal triamcinolone acetonide.
Peyman GA, Moshfeghi DM. Peyman GA, et al. Retina. 2004 Jun;24(3):488-90. doi: 10.1097/00006982-200406000-00032. Retina. 2004. PMID: 15187684 No abstract available.
Enigma of Intramuscular Triamcinolone Acetonide (Kenalog()) Efficacy.
Shahinfar S, Maibach H. Shahinfar S, et al. Clin Pharmacokinet. 2023 Sep;62(9):1189-1199. doi: 10.1007/s40262-023-01297-5. Epub 2023 Aug 19. Clin Pharmacokinet. 2023. PMID: 37598107 Review.
Triamcinolone acetonide is a glucocorticosteroid used in standard clinical practice for its anti-inflammatory properties. ...We summarize the existing literature on the pharmacokinetic and pharmacodynamic mechanisms of intramuscular triamcinolone acetonide
Triamcinolone acetonide is a glucocorticosteroid used in standard clinical practice for its anti-inflammatory properties. ...W
A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis.
Gawchik SM, Saccar CL. Gawchik SM, et al. Drug Saf. 2000 Oct;23(4):309-22. doi: 10.2165/00002018-200023040-00004. Drug Saf. 2000. PMID: 11051218 Review.
The efficacy of intranasal triamcinolone acetonide in seasonal and allergic rhinitis has been evaluated in clinical trials and has been compared with antihistamines and other intranasal corticosteroids. ...Triamcinolone acetonide at standard dosages (1 …
The efficacy of intranasal triamcinolone acetonide in seasonal and allergic rhinitis has been evaluated in clinical trials and …
Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection.
Jansen TL, Van Roon EN. Jansen TL, et al. Neth J Med. 2002 Apr;60(3):151-3. Neth J Med. 2002. PMID: 12164373 Free article.
We report four cases of secondary Cushingoid state, twice due to single, and twice due to repetitive triamcinolone acetonide (TCA: Kenacort) injection. A consulted general practitioner, internist and gynaecologist were not aware of the possibility that such a local …
We report four cases of secondary Cushingoid state, twice due to single, and twice due to repetitive triamcinolone acetonide ( …
8,177 results